Sabra Health Care REIT Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Sabra Health Care REIT wird ein jährliches Gewinn- und Umsatzwachstum von 18.8% bzw. 5.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 21.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 5.7% betragen.

Wichtige Informationen

18.8%

Wachstumsrate der Gewinne

21.5%

EPS-Wachstumsrate

Health Care REITs Gewinnwachstum	22.8%
Wachstumsrate der Einnahmen	5.8%
Zukünftige Eigenkapitalrendite	5.7%
Analystenabdeckung	Good
Zuletzt aktualisiert	17 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Sabra Health Care REIT, Inc. Just Missed EPS By 5.9%: Here's What Analysts Think Will Happen Next

May 09

Recent updates

Here's Why We Think Sabra Health Care REIT, Inc.'s (NASDAQ:SBRA) CEO Compensation Looks Fair for the time being

Jun 10

Sabra Health Care stock climbs 2.7% after Stifel turns bullish

May 10

Sabra Health Care REIT, Inc. Just Missed EPS By 5.9%: Here's What Analysts Think Will Happen Next

May 09

Sabra Health Care declares $0.30 dividend

May 05

Don't Ignore The Fact That This Insider Just Sold Some Shares In Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Mar 12

Declining Stock and Decent Financials: Is The Market Wrong About Sabra Health Care REIT, Inc. (NASDAQ:SBRA)?

Mar 02

Sabra Health Care declares $0.30 dividend

Feb 02

Have Insiders Been Selling Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares?

Jan 26

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:SBRA - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	780	185	N/A	N/A	5
12/31/2025	727	166	N/A	N/A	7
12/31/2024	682	123	N/A	N/A	7
9/30/2024	682	97	309	309	N/A
6/30/2024	666	52	295	295	N/A
3/31/2024	650	49	285	285	N/A
12/31/2023	645	14	301	301	N/A
9/30/2023	566	-88	289	289	N/A
6/30/2023	542	-123	315	315	N/A
3/31/2023	534	-128	321	321	N/A
12/31/2022	532	-78	316	316	N/A
9/30/2022	417	-17	346	346	N/A
6/30/2022	569	43	344	344	N/A
3/31/2022	399	-106	351	351	N/A
12/31/2021	388	-113	356	356	N/A
9/30/2021	587	-52	348	348	N/A
6/30/2021	444	-26	339	339	N/A
3/31/2021	601	137	349	349	N/A
12/31/2020	601	138	355	355	N/A
9/30/2020	536	141	361	361	N/A
6/30/2020	539	128	349	349	N/A
3/31/2020	615	182	393	393	N/A
12/31/2019	668	69	372	372	N/A
9/30/2019	638	10	355	355	N/A
6/30/2019	639	22	341	341	N/A
3/31/2019	587	132	313	313	N/A
12/31/2018	628	269	361	361	N/A
9/30/2018	647	390	366	366	N/A
6/30/2018	609	367	N/A	293	N/A
3/31/2018	510	192	N/A	206	N/A
12/31/2017	408	148	N/A	136	N/A
9/30/2017	301	67	N/A	96	N/A
6/30/2017	251	78	N/A	137	N/A
3/31/2017	261	95	N/A	184	N/A
12/31/2016	261	60	N/A	176	N/A
9/30/2016	266	62	N/A	176	N/A
6/30/2016	264	55	N/A	164	N/A
3/31/2016	246	34	N/A	121	N/A
12/31/2015	239	69	N/A	121	N/A
9/30/2015	228	66	N/A	93	N/A
6/30/2015	212	65	N/A	108	N/A
3/31/2015	198	63	N/A	109	N/A
12/31/2014	184	37	N/A	85	N/A
9/30/2014	165	27	N/A	84	N/A
6/30/2014	154	22	N/A	68	N/A
3/31/2014	144	7	N/A	42	N/A
12/31/2013	135	26	N/A	62	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SBRADas prognostizierte Gewinnwachstum (18.8% pro Jahr) liegt über der Sparquote (2.6%).

Ertrag vs. Markt: SBRADie Erträge des Unternehmens (18.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (15.4% pro Jahr).

Hohe Wachstumserträge: SBRADie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: SBRADie Einnahmen des Unternehmens (5.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: SBRADie Einnahmen des Unternehmens (5.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: SBRADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (5.7%).

Sabra Health Care REIT Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Sabra Health Care REIT, Inc. Updates Earnings Guidance for the Year 2024

Sabra Health Care REIT, Inc. Updates Earnings Guidance for the Year 2024

Sabra Health Care REIT, Inc. Just Missed EPS By 5.9%: Here's What Analysts Think Will Happen Next

Price target increased to US$20.14

Recent updates

Third quarter dividend of US$0.30 announced

Sabra Health Care REIT, Inc. Updates Earnings Guidance for the Year 2024

Sabra Health Care REIT, Inc. Updates Earnings Guidance for the Year 2024

New minor risk - Shareholder dilution

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Sabra Health Care REIT, Inc. to Report Q3, 2024 Results on Oct 31, 2024

Second quarter dividend of US$0.30 announced

Sabra Health Care REIT, Inc. announces Quarterly dividend, payable on August 30, 2024

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Sabra Health Care REIT, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Sabra Health Care REIT: 2 Catalysts That Should Ignite Solid Growth

First quarter dividend of US$0.30 announced

Sabra Health Care REIT, Inc. Declares Quarterly Cash Dividend, Payable on May 31, 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Sabra Healthcare REIT: An Attractive Value Proposition With Moderate Leverage

Sabra Health Care REIT, Inc., Annual General Meeting, Jun 13, 2024

Sabra Health Care REIT, Inc. to Report Q1, 2024 Results on May 08, 2024

Sabra Health Care REIT, Inc. Declares Quarterly Cash Dividend, Payable on February 29, 2024

Full year 2023 earnings released: EPS: US$0.059 (vs US$0.34 loss in FY 2022)

Sabra Health Care REIT: A Risk Worth Taking

Third quarter dividend of US$0.30 announced

Sabra Health Care REIT, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Sabra Health Care REIT, Inc. Announces Executive Changes

Insufficient new directors

Third quarter 2023 earnings: EPS misses analyst expectations

Sabra Health Care REIT, Inc. to Report Q3, 2023 Results on Nov 06, 2023

Sabra Health Care Reit, Inc. Declares A Quarterly Cash Dividend, Payable on August 31, 2023

Second quarter 2023 earnings: EPS misses analyst expectations

Sabra Health Care REIT, Inc. to Report Q2, 2023 Results on Aug 07, 2023

Upcoming dividend of US$0.30 per share at 11% yield

Sabra Health Care Reit, Inc. Reports Impairment Charges for Three Months Ended March 31, 2023

First quarter 2023 earnings: EPS misses analyst expectations

Sabra Health Care Reit, Inc. Declares Quarterly Cash Dividend, Payable on May 31, 2023

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

The Ensign Group, Inc. (NasdaqGS:ENSG) completed the acquisition of Twenty skilled nursing operations of Sabra Health Care in the state of California.

Sabra Health Care REIT, Inc. to Report Q4, 2022 Results on Feb 21, 2023

The Ensign Group, Inc. (NasdaqGS : ENSG) entered into an agreement to acquire Twenty skilled nursing operations in the state of California from Sabra Health Care REIT, Inc. (NasdaqGS : SBRA).

Third quarter 2022 earnings: Revenues miss analyst expectations

Sabra Health Care REIT, Inc. Declares Quarterly Cash Dividend, Payable on November 30, 2022

Sabra Health Care REIT, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Sabra Health Care REIT Pays A Good Dividend

Upcoming dividend of US$0.30 per share

Sabra Health Care declares $0.30 dividend

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Sabra Health Care REIT, Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2022

Sabra Health Care REIT, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Sabra Health Care: 8.45% Dividend Yield With Limited Downside Risk

The Ensign Group, Inc. (NasdaqGS:ENSG) acquired the Real Estate and Operations of McKinney Healthcare and Rehabilitation Center from Sabra Health Care REIT, Inc. (NasdaqGS:SBRA).

Sabra: Strong, Steady Dividend, But Also Needs Capacity Building

Sienna Senior Living Inc. (TSX:SIA) and Sabra Health Care REIT, Inc. (NasdaqGS:SBRA) completed the acquisition of Portfolio of Eleven Private-Pay Retirement Residences in Ontario and Saskatchewan from Extendicare Inc. (TSX:EXE) for approximately CAD 310 million.

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Sabra Health Care REIT, Inc. Declares Quarterly Cash Dividend, Payable on May 31, 2022

Sabra Health Care REIT, Inc., Annual General Meeting, Jun 14, 2022

Sabra Health Care REIT, Inc. to Report Q1, 2022 Results on May 04, 2022

Sabra: FFO Likely To Drop 10% In 2022

An unknown buyer acquired Four Skilled Nursing/Transitional Care Facilities, Two Senior Housing Communities and Two Hospitals from Sabra Health Care REIT, Inc. (NasdaqGS:SBRA) for $85.9 million.

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Sabra Health Care REIT, Inc. Announces Resignation of Raymond J. Lewis as Board of Directors

Sienna Senior Living Inc. (TSX:SIA) and Sabra Health Care REIT, Inc. (NasdaqGS:SBRA) entered into an agreement to acquire Portfolio of Eleven Private-Pay Retirement Residences in Ontario and Saskatchewan from Extendicare Inc. (TSX:EXE) for approximately CAD 310 million.

Sabra Health Care REIT, Inc. Declares Quarterly Cash Dividend, Payable on February 28, 2022

Consultant recently sold US$1.5m worth of stock

Sabra Health Care: A Monster Yield At A Good Price

Sabra Health Care: This 8.8% Yield REIT Is Trading At A Discount

Sabra Health Care REIT: Stresses Pick Up In Q3

Upcoming dividend of US$0.30 per share

Third quarter 2021 earnings released: EPS US$0.046 (vs US$0.18 in 3Q 2020)

Reasons That Make Sabra A Great Fit To Be Acquired By Welltower

Upcoming dividend of US$0.30 per share

Second quarter 2021 earnings released: US$0.61 loss per share (vs US$0.14 profit in 2Q 2020)

6.5% Yield: Sabra Is An Oasis Of Value In A Frothy Market

Here's Why We Think Sabra Health Care REIT, Inc.'s (NASDAQ:SBRA) CEO Compensation Looks Fair for the time being